August 2021 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Articles
CEO Corner
- What The Sale Of Agios’ Oncology Pipeline Taught Me
- How European Biopharmas Can Benefit From Establishing A U.S. Presence
Companies To Watch
Industry Research
Inside The Industry
- After The Pandemic, Who’s Coming To The Office?
- IPO, M&A, And SPAC — 3 Life Science Execs Recount Going Public
- Why Bioscience Will Increasingly Call The Plays
- Are Oral Dose Manufacturing Projects Becoming More Complicated?
- A Q&A With A Biotech Founder/Entrepreneur
- Coming Out Of Stealth Mode: What To Know And Do
- How Pharma Executives View Future Business Travel
Industry Leader
Leadership Lessons
Ask The Board
- What Is The Right Time For An Emerging Company To Refresh The Board To A More Commercial Orientation Prior To The Commercialization Of Its First Product?
- What Are The Characteristics Of Your Best Mentor?
- Given The Risk Profile Of An Emerging Company, What Is The Appropriate Compensation Mix Between Salary, Short-, And Long-Term (Stock) To Attract Talent?
This website uses cookies to ensure you get the best experience on our website. Learn more